Centessa Pharmaceuticals (CNTA) Exchange Rate Effect (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Exchange Rate Effect of $182000.0 for Q1 2026, up 112.0% year-over-year from $85850.1 in Q1 2025, and down 89.19% on a QoQ basis from $1.7 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 7 years of Exchange Rate Effect data on file, last reported at $182000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 112.0% year-over-year to $182000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 345.78% YoY) and the FY2025 annual result came in at -$448000.0, down 136.51% from the prior year.
- Exchange Rate Effect slipped to $182000.0 in Q1 2026 per CNTA's latest filing, from $1.7 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3.0 million in Q4 2024 and bottomed at -$1.9 million in Q3 2024.
- The 5-year median for Exchange Rate Effect is -$113000.0 (2025), against an average of $68117.6.
- Peak annual rise in Exchange Rate Effect reached 701.59% in 2024, while the deepest fall reached 965.45% in 2024.
- Tracing CNTA's Exchange Rate Effect over 5 years: stood at $722000.0 in 2022, then slumped by 169.81% to -$504000.0 in 2023, then jumped by 701.59% to $3.0 million in 2024, then tumbled by 44.49% to $1.7 million in 2025, then sank by 89.19% to $182000.0 in 2026.
- Per Business Quant, the three latest CNTA Exchange Rate Effect figures stand at $182000.0 (Q1 2026), $1.7 million (Q4 2025), and -$501000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | 182,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 182,000.00 |
| Mar 31, 2026 | 182,000.00 |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | -501,000.00 |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Mar 31, 2025 | -1.52 Mn |
| Mar 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | -120,000.00 |
| Jun 30, 2024 | -120,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Dec 31, 2023 | -504,000.00 |
| Dec 31, 2023 | -504,000.00 |
| Sep 30, 2023 | 220,000.00 |
| Sep 30, 2023 | 220,000.00 |
| Jun 30, 2023 | 381,000.00 |
| Jun 30, 2023 | 381,000.00 |
| Mar 31, 2023 | 518,000.00 |
| Mar 31, 2023 | 518,000.00 |
| Dec 31, 2022 | 722,000.00 |
| Dec 31, 2022 | 722,000.00 |
| Sep 30, 2022 | -438,000.00 |
| Sep 30, 2022 | -438,000.00 |
| Jun 30, 2022 | -268,000.00 |
| Jun 30, 2022 | -268,000.00 |
| Mar 31, 2022 | -434,000.00 |
| Mar 31, 2022 | -434,000.00 |
| Dec 31, 2021 | -1.67 Mn |
| Dec 31, 2021 | -1.67 Mn |
| Sep 30, 2021 | 265,000.00 |
| Sep 30, 2021 | 265,000.00 |
| Jun 30, 2021 | 3.35 Mn |
| Jun 30, 2021 | 3.35 Mn |
| Mar 31, 2021 | -124,000.00 |
| Mar 31, 2021 | -124,000.00 |
| Dec 31, 2020 | 355,000.00 |
| Dec 31, 2020 | 355,000.00 |
| Sep 30, 2020 | 491,000.00 |
| Sep 30, 2020 | 491,000.00 |